Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?
Publication
, Journal Article
Granger, CB
Published in: Circulation
December 5, 2006
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
December 5, 2006
Volume
114
Issue
23
Start / End Page
2432 / 2433
Location
United States
Related Subject Headings
- Stroke Volume
- Risk Factors
- Razoxane
- Predictive Value of Tests
- Humans
- Heart
- Dose-Response Relationship, Drug
- Cardiovascular System & Hematology
- Cardiovascular Agents
- Cardiomyopathies
Citation
APA
Chicago
ICMJE
MLA
NLM
Granger, C. B. (2006). Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done? Circulation, 114(23), 2432–2433. https://doi.org/10.1161/CIRCULATIONAHA.106.666248
Granger, Christopher B. “Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?” Circulation 114, no. 23 (December 5, 2006): 2432–33. https://doi.org/10.1161/CIRCULATIONAHA.106.666248.
Granger CB. Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done? Circulation. 2006 Dec 5;114(23):2432–3.
Granger, Christopher B. “Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?” Circulation, vol. 114, no. 23, Dec. 2006, pp. 2432–33. Pubmed, doi:10.1161/CIRCULATIONAHA.106.666248.
Granger CB. Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done? Circulation. 2006 Dec 5;114(23):2432–2433.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
December 5, 2006
Volume
114
Issue
23
Start / End Page
2432 / 2433
Location
United States
Related Subject Headings
- Stroke Volume
- Risk Factors
- Razoxane
- Predictive Value of Tests
- Humans
- Heart
- Dose-Response Relationship, Drug
- Cardiovascular System & Hematology
- Cardiovascular Agents
- Cardiomyopathies